New drugs may hold the key to melanoma treatment
By Catholic Online (NEWS CONSORTIUM)
6/3/2014 (2 years ago)
Catholic Online (www.catholic.org)
Two new drugs may provide an exciting and striking treatment option for those who suffer from advanced cases of melanoma.
Image scans of Steele's lungs before and after his treatment. The left scan shows numerous gray colored cancer tissues, which are gone in the right, after his treatment.
LOS ANGELES, CA (Catholic Online) - In separate international trials, new drugs pembrolizumab and nivolumab, have seen great success treating melanoma, which is the most dangerous type of skin cancer, and also causes the most amount of deaths of any skin disease. When melanoma spreads to other organs it is very difficult to treat, and, until a few years ago, average survival was around half a year.
Both drugs are designed to help the immune system recognize and target cancerous cells by blocking the biological pathway the cancers use to disguise themselves from the immune system.
Pembrolizumab, formerly known as MK-3475, was tested on 411 patients, of which 69% survived for at least one year. This drug is also being tested on cancers which utilize a similar method to block attacks from the immune system.
"Pembrolizumab looks like it has potential to be a paradigm shift for cancer therapy," said Dr. David Chao, consultant oncologist at the Royal Free London NHS Foundation Trust. Chao is conducting trials on melanoma and lung cancer patients.
64-year-old Warwick Steele has been receiving infusions of the drug every three weeks since October, and has seen phenomenal results.
"I got tired simply standing up and was literally too exhausted to shave. But now I feel back to normal and can do gardening and go shopping," he said.
Prior to his treatment, Steele could barely walk because the cancers in his lungs made it hard to breath. Scans have shown that just after three infusions, the cancer seems to have been totally cleared out of his lungs.
Nivolumab, which was tested in conjunction with the existing immunotherapy ipilimumab, saw 85% of its' 53 patients survive past a year, and 79% after two years.
Copyright 2017 - Distributed by THE CALIFORNIA NETWORK
Pope Francis Prayer Intentions for FEBRUARY 2017
Comfort for the Afflicted. That all those who are afflicted, especially the poor, refugees, and marginalized, may find welcome and comfort in our communities.
"God doesn't ask us to be super-heroes," assured Cardinal Pietro Parolin, on February 11, 2017, the 25th World Day of the Sick. ... continue reading
(Vatican Radio) Pope Francis on Friday spoke about the situations of "light and shadow" in the healthcare sector, thanking God for ... continue reading
Researchers have uncovered the grave of an unusual leprosy patient from medieval England. His bones tell a story that could help rewrite ... continue reading
As we approach both Christmas and the New Year, many of us like to take stock of the past year and to make concrete plans for the next. ... continue reading
For decades, doctors have warned that germs are evolving faster than we can produce new antibiotics to kill them. Eventually our ... continue reading
by Catholic Online
- Massive storm threatens to flood more than just the Oroville Dam HD Video
- Catholics Should Read, Pray, Live and Love the Bible as the Word of God
- Bl. Alvarez of Corova: Saint of the Day for Sunday, February 19, 2017
- Your Daily Inspirational Meme: Pope Francis
- Daily Reading for Wednesday, February 22nd, 2017 HD Video
- Daily Readings for Sunday, February 19, 2017
- Former mobster cleans up and becomes a preacher - 'I believe it was ...
- Daily Reading for Tuesday, February 21st, 2017 HD
- Daily Reading for Monday, February 20th, 2017 HD
- Daily Reading for Sunday, February 19th, 2017 HD
- Daily Reading for Saturday, February 18th, 2017 HD
How to Pray the Rosary
The Rosary is a Scripture-based prayer to help us remember the ... @ $0.00
Copyright 2017 Catholic Online. All materials contained on this site, whether written, audible or visual are the exclusive property of Catholic Online and are protected under U.S. and International copyright laws, © Copyright 2017 Catholic Online. Any unauthorized use, without prior written consent of Catholic Online is strictly forbidden and prohibited.